EP0123734A1 — 17-(Isocyano-sulfonylmethylene)-steroids, 17-(formamido-sulfonylmethylene)-steroids and their preparation
Assigned to Gist Brocades NV · Expires 1984-11-07 · 42y expired
What this patent protects
The invention relates to 17-(isocyano-sulfonyl- methylene)-steroids and a process for the preparation of these compounds. Furthermore the invention relates to 17-(formamido-sulfonylmethylene)-steroids, which compounds are, intermediates in the preparation of the 17-(isocyano- sul…
USPTO Abstract
The invention relates to 17-(isocyano-sulfonyl- methylene)-steroids and a process for the preparation of these compounds. Furthermore the invention relates to 17-(formamido-sulfonylmethylene)-steroids, which compounds are, intermediates in the preparation of the 17-(isocyano- sulfonylmethylene)-steroids, and a process for the preparation of these compounds.
Drugs covered by this patent
- Abilify (aripiprazole) · Generic (originally Otsuka/BMS)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.